Toward Risk-Benefit Assessments in Psychedelic- and MDMA-Assisted Therapies
Mazdak M. Bradberry, Natalie Gukasyan, Charles L. Raison
JAMA Psychiatry April 27, 2022 DOI: 10.1001/jamapsychiatry.2022.0665 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Peer reviewed |
|---|---|
| Topics | MDMA Psychedelic-assisted therapy |
| Keywords | Otorhinolaryngology Neurology Family medicine |
| Citations | 20 |
Abstract
Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA Psychiatry HomeNew OnlineCurrent IssueFor Authors Podcast Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA Psychiatry journal
Citations in the library
Cited by 15
- Psychedelic Drug Legislative Reform and Legalization in the US JAMA Psychiatry December 7, 2022
- Policy considerations that support equitable access to responsible, accountable, safe, and ethical uses of psychedelic medicines Neuropharmacology August 13, 2022
- Developing an Ethics and Policy Framework for Psychedelic Clinical Care: A Consensus Statement. JAMA Network Open June 3, 2024
- Adolescent Psychedelic Use and Psychotic or Manic Symptoms JAMA Psychiatry March 13, 2024
- Prevalence and therapeutic impact of adverse life event reexperiencing under ceremonial ayahuasca. Scientific Reports June 9, 2023
and 10 more in the library
Cites 7
- Human hallucinogen research: guidelines for safety. Journal of Psychopharmacology July 1, 2008
- The safety and efficacy of {+/-}3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study. Journal of Psychopharmacology July 19, 2010
- ADVERSE REACTIONS TO PSYCHEDELIC DRUGS. A REVIEW OF THE LITERATURE The Journal of Nervous and Mental Disease October 1, 1984
- Long-term follow-up outcomes of MDMA-assisted psychotherapy for treatment of PTSD: a longitudinal pooled analysis of six phase 2 trials. Psychopharmacology August 1, 2020
- Prolonged Adverse Reactions to Lysergic Acid Diethylamide Archives of General Psychiatry May 1, 1963
and 2 more in the library